ArticleCancers2023

CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer.

Aleksandra Semeniuk-Wojtaś et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.